Financials in USD. Standardized financial statements.
A compact view of how Theralase Technologies Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $816,468 | $1.03M | $1.07M | $1.14M | $780,641 | $929,122 | $964,051 | $1.73M | $2.34M | $1.92M |
| Revenue Growth? | -21.0% | -3.4% | -6.0% | +45.9% | -16.0% | -3.6% | -44.4% | -26.0% | +22.1% | 0.0% |
| Cost of Revenue? | $309,337 | $479,405 | $508,173 | $510,395 | $470,698 | $659,442 | $903,296 | $786,433 | $945,010 | $796,569 |
| Gross Profit? | $507,131 | $554,026 | $562,134 | $628,174 | $309,943 | $269,680 | $60,755 | $947,639 | $1.40M | $1.12M |
| Gross Margin? | +62.1% | +53.6% | +52.5% | +55.2% | +39.7% | +29.0% | +6.3% | +54.6% | +59.7% | +58.5% |
| Operating Expenses? | $4.68M | $4.84M | $5.31M | $5.86M | $4.85M | $5.97M | $7.48M | $4.31M | $7.48M | -$3.80M |
| Operating Income? | -$4.18M | -$4.29M | -$4.59M | -$5.23M | -$4.54M | -$5.59M | -$7.39M | -$3.37M | -$6.08M | -$5.11M |
| EBITDA? | -$3.81M | -$3.96M | -$4.25M | -$4.90M | -$4.13M | -$5.32M | -$7.15M | -$3.13M | -$5.84M | -$4.77M |
| Income Before Tax | -$4.12M | -$4.26M | -$4.57M | -$5.24M | -$4.41M | -$5.60M | -$7.41M | -$3.36M | -$6.09M | -$4.92M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$4.12M | -$4.26M | -$4.57M | -$5.24M | -$4.41M | -$5.60M | -$7.41M | -$3.36M | -$6.09M | -$4.92M |
| EPS? | $-0.02 | $-0.02 | $-0.02 | $-0.03 | $-0.02 | $-0.03 | $-0.05 | $-0.03 | $-0.05 | $-0.05 |
| Diluted EPS? | $-0.02 | $-0.02 | $-0.02 | $-0.03 | $-0.02 | $-0.03 | $-0.05 | $-0.03 | $-0.05 | $-0.05 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality